Published in Diabetes Care on January 01, 1990
Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21
Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes (2000) 4.80
Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J (2003) 2.02
Clinical practice guidelines for treatment of diabetes mellitus. Expert Committee of the Canadian Diabetes Advisory Board. CMAJ (1992) 1.90
Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest (1992) 1.33
The prince and the pauper. A tale of anticancer targeted agents. Mol Cancer (2008) 1.12
Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst (2009) 1.09
The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats. Lipids Health Dis (2005) 0.92
Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin. J Clin Invest (1993) 0.86
Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase- lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes (2013) 0.86
Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors. Drugs (1992) 0.85
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care (2013) 0.82
Regulation by metformin of the hexose transport system in vascular endothelial and smooth muscle cells. Br J Pharmacol (1996) 0.82
Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data. Nephron (2016) 0.81
Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity. Cardiovasc Diabetol (2015) 0.79
Use of Metformin in Patients with Kidney and Cardiovascular Diseases. Cardiorenal Med (2011) 0.78
Use of metformin in diseases of aging. Curr Diab Rep (2014) 0.77
Effects of metformin on the regulation of free Fatty acids in insulin resistance: a double-blind, placebo-controlled study. J Nutr Metab (2012) 0.77
Metformin does not enhance insulin-stimulated vasodilation in skeletal muscle resistance arteries of the OLETF rat. Microcirculation (2013) 0.77
Killing two birds with one stone, maybe: CETP inhibition increases both high-density lipoprotein levels and insulin secretion. Circ Res (2013) 0.75
Metformin-Associated Lactic Acidosis in a Patient With Normal Renal Function. Clin Diabetes (2015) 0.75
Metformin Suppresses MHC-Restricted Antigen Presentation by Inhibiting Co-Stimulatory Factors and MHC Molecules in APCs. Biomol Ther (Seoul) (2013) 0.75
Randomized Placebo Control Study of Metformin in Psoriasis Patients with Metabolic Syndrome (Systemic Treatment Cohort). Indian J Endocrinol Metab (2017) 0.75
The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell (1985) 7.45
Stochastics of cycle completions (fluxes) in biochemical kinetic diagrams. Proc Natl Acad Sci U S A (1975) 4.38
Insulin resistance and cigarette smoking. Lancet (1992) 4.10
On the theory of ion transport across the nerve membrane. II. Potassium ion kinetics and cooperativity (with x = 4). Proc Natl Acad Sci U S A (1971) 3.94
Temporal processing deficits of language-learning impaired children ameliorated by training. Science (1996) 3.80
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes (1988) 3.67
High-throughput genotyping with single nucleotide polymorphisms. Genome Res (2001) 3.55
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol (1999) 3.50
Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab (2001) 3.31
Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA (1994) 3.30
On the theory of ion transport across the nerve membrane. IV. Noise from the open-close kinetics of K + channels. Biophys J (1972) 3.11
On the theory of ion transport across the nerve membrane. 3. Potassium ion kinetics and cooperativity (with x=4,6,9). Proc Natl Acad Sci U S A (1971) 3.11
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA (1991) 3.01
Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Diabetologia (2009) 2.98
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia (2007) 2.71
Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest (1970) 2.68
Some self-consistent two-state sliding filament models of muscle contraction. Biophys J (1975) 2.65
Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study. J Perinatol (2008) 2.64
Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest (1985) 2.64
Distribution of the wingless gene product in Drosophila embryos: a protein involved in cell-cell communication. Cell (1989) 2.61
Coronary artery disease in Chinese males without hypercholesterolaemia. J Intern Med (1990) 2.54
Monte Carlo study of the GTP cap in a five-start helix model of a microtubule. Proc Natl Acad Sci U S A (1985) 2.51
Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med (1995) 2.50
A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism (2000) 2.49
Fructose-induced insulin resistance and hypertension in rats. Hypertension (1987) 2.43
Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women. Diabetes Care (1997) 2.40
Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer (2004) 2.30
Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care (2000) 2.22
Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab (1998) 2.21
Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes (2001) 2.21
Control of Drosophila body pattern by the hunchback morphogen gradient. Cell (1992) 2.16
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia (2009) 2.04
Borders of parasegments in Drosophila embryos are delimited by the fushi tarazu and even-skipped genes. Nature (1987) 2.00
Role of insulin in endogenous hypertriglyceridemia. J Clin Invest (1967) 2.00
Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther (1990) 1.99
Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action. Proc Natl Acad Sci U S A (1977) 1.97
Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1987) 1.96
Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest (1974) 1.92
Cooperative effects in models of steady-state transport across membranes. II. Oscillating phase transition. Proc Natl Acad Sci U S A (1970) 1.90
Liver transplantation in 100 children: Cambridge and King's College Hospital series. BMJ (1992) 1.90
Cooperative effects in models of steady-state transport across membranes. IV. One-site, two-site, and multisite models. Biophys J (1971) 1.89
Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia (1994) 1.87
Fluctuations and noise in kinetic systems. Application to K+ channels in the squid axon. Biophys J (1973) 1.87
Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med (1974) 1.84
Kinetics of triglyceride turnover of very low density lipoproteins of human plasma. J Clin Invest (1965) 1.83
Insulin resistance in pulmonary arterial hypertension. Eur Respir J (2008) 1.80
Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology (1984) 1.79
How enzymes can capture and transmit free energy from an oscillating electric field. Proc Natl Acad Sci U S A (1986) 1.78
Different requirements for homeotic genes in the soma and germ line of Drosophila. Cell (1983) 1.77
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest (1993) 1.75
A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes (1994) 1.73
Analysis of a simple prototypal muscle model near to and far from equilibrium. Proc Natl Acad Sci U S A (1974) 1.73
Elevated insulin receptor content in human breast cancer. J Clin Invest (1990) 1.70
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest (1975) 1.69
Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic acinar AR42J cells. J Cell Biol (1985) 1.68
Interacting enzyme systems at steady state: location of the phase transition in approximations of the mean field type. Proc Natl Acad Sci U S A (1978) 1.67
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene (1999) 1.66
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001). Eur J Cancer (2002) 1.66
Phenocopies induced with antisense RNA identify the wingless gene. Cell (1987) 1.64
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res (1999) 1.63
Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women. Am J Clin Nutr (1997) 1.62
Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes (2000) 1.62
Separating individual skin conductance responses in a short interstimulus-interval paradigm. J Neurosci Methods (2005) 1.59
Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action. Proc Natl Acad Sci U S A (1982) 1.57
Insulin action in isolated rat thymocytes. I. Binding of 125 I-insulin and stimulation of -aminoisobutyric acid transport. J Biol Chem (1972) 1.56
A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes (1999) 1.56
Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat. J Biol Chem (1974) 1.55
Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism (1998) 1.54
Differentiation between equilibrium and nonequilibrium kinetic systems by noise analysis. Biophys J (1978) 1.54
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol (2001) 1.53
DNA synthesis in human fibroblasts: stimulation by insulin and by nonsuppressible insulin-like activity (NSILA-S). J Clin Endocrinol Metab (1974) 1.53
Insulin binding to isolated human adipocytes. Diabetes (1974) 1.53
The consequences of ubiquitous expression of the wingless gene in the Drosophila embryo. Development (1992) 1.52
Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res (1993) 1.51
Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology (1975) 1.50
Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care (1998) 1.49
Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes (1977) 1.49
Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man. Recent Prog Horm Res (1975) 1.47
Effect of age on glucose tolerance and glucose uptake in healthy individuals. J Am Geriatr Soc (1989) 1.47
From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia (1997) 1.46
Tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Intern Med (2000) 1.46
Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab (1988) 1.46
Interacting enzyme systems at steady state: further Monte Carlo calculations on two-state molecules. Proc Natl Acad Sci U S A (1978) 1.44
Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care (1994) 1.44
Much ado about (almost) nothing. Diabetes Care (1997) 1.43
Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes (1981) 1.42